Medical contraindications are not a major factor in the underutilization of breast conserving therapy

Journal of the American College of Surgeons

Volumn 186, Issue 3, 1998, Pages 269-274

  Morrow, Monica ^a   Bucci, Cathy ^a   Rademaker, Alfred ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGE; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST SURGERY; CANCER STAGING; CANCER SURVIVAL; CLINICAL PRACTICE; EARLY CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PARTIAL MASTECTOMY; PATIENT SELECTION; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; TREATMENT CONTRAINDICATION; TUMOR VOLUME;

EID: 0031940652     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1072-7515(97)00153-1     Document Type: Article

References (23)

1. Veronesi U, Salvadori B, Luini A, et al. Breast conservation is a safe method in patients with small cancer of the breast. Long term results of three randomized trials on 1973 patients. Eur J Cancer 1995;31A:1574-1579.
2. Fisher B, Redmond C, Poisson R, et al. Eight year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1989;430:822-828.
3. Sarrazin D, Le MG, Arriagada R, et al. Ten year results of a randomized trial comparing a conservative treatment to mastectomy in early breast cancer. Radiother Oncol 1989;14:177-184.
4. Van Dongen JA, Bartelink H, Fentiman IS, et al. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC Trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 1992;28A:801-805.
5. Lichter AS, Lippman ME, Danforth DN, et al. Mastectomy versus breast conserving therapy in the treatment of stage I and II carcinoma of the breast: a randomized trial at the National Cancer Institute. J Clin Oncol 1992;10:976-983.
6. Osteen RT, Winchester DP, and Cunningham MP. Breast Cancer. In Steele GD Jr, Jessup JM, Winchester DP, et al., eds. National Cancer Data Base Annual Review of Patient Care, 1995. Atlanta, GA: American Cancer Society, 1995:12-35.
7. Lazovich D, White E, Thomas DB, and Moe RE. Underutilization of breast-conserving surgery and radiation therapy among women with stage I or II breast cancer. JAMA 1991;266: 3433-3438.
8. Farrow DC, Hunt WC, and Samet JM. Geographic variation in the treatment of localized breast cancer. N Engl J Med 1992;326:1097-1011.
9. Kotwall CA, Covington DL, Rutledge R, et al. Patient, hospital, and surgeon factors associated with breast conservation surgery. A statewide analysis in North Carolina. Ann Surg 1996;224:419-429.
10. Nattinger AB, Gottlieb MS, Hoffman RG, et al. Minimal increase in use of breast-conserving surgery from 1986 to 1990. Med Care 1996;34:479-489.
11. Samet JM, Hunt WC, and Farrow DC. Determinants of receiving breast-conserving surgery. The Surveillance, Epidemiology, and End Results Program, 1983-1986. Cancer 1994;73:2344-2351.
12. Foster RS, Farwell ME, and Costanza MC. Breast-conserving for breast cancer: patterns of care in a geographic region and estimation of potential applicability. Ann Surg Oncol 1995;2:275-280.
13. Miller BA, Feuer EJ, and Hankey BF. The significance of the rising incidence of breast cancer in the United States. In DeVita VT, Hellman S, and Rosenberg SA (eds). Important Advances In Oncology, 1994. Philadelphia: J Lippincott-Raven; 1994:193-210.
14. Wolberg WH. Surgical options in 424 patients with primary breast cancer without systemic metastases. Arch Surg 1991; 126:817-820.
15. Tate P, McGee E, Hopkins S, et al. Breast conservation versus mastectomy: patient preference in a community practice in Kentucky. J Surg Oncol 1993;52:213-216.
16. Winchester D, and Cox J. Standards for breast conservation treatment. Ca Cancer J Clin 1992;42:134-157.
17. Lichter A, Green S, Albain K, et al. The influence of patient characteristics, socioeconomic status (SES) factors, geography, and systemic risk on the use of breast sparing treatment in adjuvant breast cancer studies. Proc Am Soc Clin Oncol 1994;13:62.
18. Powles TJ, Hickish TF, Makris A, et al. Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer. J Clin Oncol 1995;13:547-552.
19. Bonadonna G, Veronesi U, Brambilla C, et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 1990;82:1539-1545.
20. Mamounas E, Fisher B, Rockette H, et al. Clinical and pathologic local-regional response of operable breast cancer (BC) to preoperative chemotherapy. Results for NSABP B18. Society of Surgical Oncology 49th Annual Cancer Symposium, March 1996, Atlanta, GA.
21. Tarbox BB, Rockwood JK, and Abernathy CM. Are modified radical mastectomies done for T1 breast cancers because of surgeon's advice or patient's choice? Am J Surg 1992;164:417-421.
22. Nattinger AB, Hoffmann RG, Shapiro R, et al. The effect of legislative requirements on the use of breast-conserving surgery. N Engl J Med 1996;335:1035-1040.
23. Morrow M, Schmidt R, and Hassett C. Patient selection for breast conservation therapy with magnification mammography. Surgery 1995;118:621-626.